Reshma Jagsi1, Manjeet Chadha2, Janaki Moni2, Karla Ballman2, Fran Laurie2, Thomas A Buchholz2, Armando Giuliano2, Bruce G Haffty2. 1. Reshma Jagsi, University of Michigan, Ann Arbor, MI; Manjeet Chadha, Beth Israel Medical Center, New York, NY; Janaki Moni, University of Massachusetts Medical School, Worcester, MA; Janaki Moni and Fran Laurie, Quality Assurance Review Center, Lincoln, RI; Karla Ballman, Alliance Statistics and Data Center, Mayo Clinic, Rochester, MN; Thomas A. Buchholz, MD Anderson Cancer Center, Houston, TX; Armando Giuliano, Cedars-Sinai Medical Center, Los Angeles, CA; and Bruce G. Haffty, Rutgers-Cancer Institute of New Jersey, New Brunswick, NJ. rjagsi@med.umich.edu. 2. Reshma Jagsi, University of Michigan, Ann Arbor, MI; Manjeet Chadha, Beth Israel Medical Center, New York, NY; Janaki Moni, University of Massachusetts Medical School, Worcester, MA; Janaki Moni and Fran Laurie, Quality Assurance Review Center, Lincoln, RI; Karla Ballman, Alliance Statistics and Data Center, Mayo Clinic, Rochester, MN; Thomas A. Buchholz, MD Anderson Cancer Center, Houston, TX; Armando Giuliano, Cedars-Sinai Medical Center, Los Angeles, CA; and Bruce G. Haffty, Rutgers-Cancer Institute of New Jersey, New Brunswick, NJ.
Abstract
PURPOSE: ACOSOG Z0011 established that axillary lymph node dissection (ALND) is unnecessary in patients with breast cancer with one to two positive sentinel lymph nodes (SLNs) who undergo lumpectomy, radiotherapy (RT), and systemic therapy. We sought to ascertain RT coverage of the regional nodes in that trial. METHODS: We evaluated case report forms completed 18 months after enrollment. From 2012 to 2013, we collected all available detailed RT records for central review. RESULTS: Among 605 patients with completed case report forms, 89% received whole-breast RT. Of these, 89 (15%) were recorded as also receiving treatment to the supraclavicular region. Detailed RT records were obtained for 228 patients, of whom 185 (81.1%) received tangent-only treatment. Among 142 with sufficient records to evaluate tangent height, high tangents (cranial tangent border ≤ 2 cm from humeral head) were used in 50% of patients (33 of 66) randomly assigned to ALND and 52.6% (40 of 76) randomly assigned to SLND. Of the 228 patients with records reviewed, 43 (18.9%) received directed regional nodal RT using ≥ three fields: 22 in the ALND arm and 21 in the SLND arm. Those receiving directed nodal RT had greater nodal involvement (P < .001) than those who did not. Overall, there was no significant difference between treatment arms in the use of protocol-prohibited nodal fields. CONCLUSION: Most patients treated in Z0011 received tangential RT alone, and some received no RT at all. Some patients received directed nodal irradiation via a third field. Further research is necessary to determine the optimal RT approach in patients with low-volume axillary disease treated with SLND alone.
RCT Entities:
PURPOSE: ACOSOG Z0011 established that axillary lymph node dissection (ALND) is unnecessary in patients with breast cancer with one to two positive sentinel lymph nodes (SLNs) who undergo lumpectomy, radiotherapy (RT), and systemic therapy. We sought to ascertain RT coverage of the regional nodes in that trial. METHODS: We evaluated case report forms completed 18 months after enrollment. From 2012 to 2013, we collected all available detailed RT records for central review. RESULTS: Among 605 patients with completed case report forms, 89% received whole-breast RT. Of these, 89 (15%) were recorded as also receiving treatment to the supraclavicular region. Detailed RT records were obtained for 228 patients, of whom 185 (81.1%) received tangent-only treatment. Among 142 with sufficient records to evaluate tangent height, high tangents (cranial tangent border ≤ 2 cm from humeral head) were used in 50% of patients (33 of 66) randomly assigned to ALND and 52.6% (40 of 76) randomly assigned to SLND. Of the 228 patients with records reviewed, 43 (18.9%) received directed regional nodal RT using ≥ three fields: 22 in the ALND arm and 21 in the SLND arm. Those receiving directed nodal RT had greater nodal involvement (P < .001) than those who did not. Overall, there was no significant difference between treatment arms in the use of protocol-prohibited nodal fields. CONCLUSION: Most patients treated in Z0011 received tangential RT alone, and some received no RT at all. Some patients received directed nodal irradiation via a third field. Further research is necessary to determine the optimal RT approach in patients with low-volume axillary disease treated with SLND alone.
Authors: Bernard Fisher; Jong-Hyeon Jeong; Stewart Anderson; John Bryant; Edwin R Fisher; Norman Wolmark Journal: N Engl J Med Date: 2002-08-22 Impact factor: 91.245
Authors: Kristen P Massimino; Crystal J Hessman; Michelle C Ellis; Arpana M Naik; John T Vetto Journal: Am J Surg Date: 2012-03-24 Impact factor: 2.565
Authors: Sarah M Gainer; Kelly K Hunt; Peter Beitsch; Abigail S Caudle; Elizabeth A Mittendorf; Anthony Lucci Journal: Ann Surg Oncol Date: 2012-07-21 Impact factor: 5.344
Authors: P J Schlembach; T A Buchholz; M I Ross; S M Kirsner; G J Salas; E A Strom; M D McNeese; G H Perkins; K K Hunt Journal: Int J Radiat Oncol Biol Phys Date: 2001-11-01 Impact factor: 7.038
Authors: Armando E Giuliano; Linda McCall; Peter Beitsch; Pat W Whitworth; Peter Blumencranz; A Marilyn Leitch; Sukamal Saha; Kelly K Hunt; Monica Morrow; Karla Ballman Journal: Ann Surg Date: 2010-09 Impact factor: 12.969
Authors: Abigail S Caudle; Kelly K Hunt; Henry M Kuerer; Funda Meric-Bernstam; Anthony Lucci; Isabelle Bedrosian; Gildy V Babiera; Rosa F Hwang; Merrick I Ross; Barry W Feig; Karen Hoffman; Jennifer K Litton; Aysegul A Sahin; Wei Yang; Gabriel N Hortobagyi; Thomas A Buchholz; Elizabeth A Mittendorf Journal: Ann Surg Oncol Date: 2011-09 Impact factor: 5.344
Authors: Armando E Giuliano; Kelly K Hunt; Karla V Ballman; Peter D Beitsch; Pat W Whitworth; Peter W Blumencranz; A Marilyn Leitch; Sukamal Saha; Linda M McCall; Monica Morrow Journal: JAMA Date: 2011-02-09 Impact factor: 56.272
Authors: Laura S Dominici; Monica Morrow; Elizabeth Mittendorf; Jennifer Bellon; Tari A King Journal: Curr Probl Surg Date: 2016-11-29 Impact factor: 1.909
Authors: M-L Sautter-Bihl; F Sedlmayer; W Budach; J Dunst; P Feyer; R Fietkau; W Haase; W Harms; M D Piroth; R Souchon; F Wenz; R Sauer Journal: Strahlenther Onkol Date: 2014-10 Impact factor: 3.621
Authors: Tristan C F van Heijst; Bram van Asselen; Ruud M Pijnappel; Marissa Cloos-van Balen; Jan J W Lagendijk; Desirée van den Bongard; Mariëlle E P Philippens Journal: Br J Radiol Date: 2016-05-10 Impact factor: 3.039
Authors: Elizabeth FitzSullivan; Roland L Bassett; Henry M Kuerer; Elizabeth A Mittendorf; Min Yi; Kelly K Hunt; Gildy V Babiera; Abigail S Caudle; Dalliah M Black; Isabelle Bedrosian; Chantal Reyna; Mediget Teshome; Funda Meric-Bernstam; Rosa Hwang Journal: Ann Surg Oncol Date: 2016-10-03 Impact factor: 5.344